Acquisition Opportunities Vanda Pharmaceuticals has recently attracted acquisition interest from companies like Cycle Pharmaceuticals and Future Pak Ltd, signaling opportunities for strategic partnerships or potential sales of the company.
Investment Interest Institutions like Mackenzie Investments have shown interest in investing in Vanda Pharmaceuticals, indicating potential avenues for partnership or collaboration that could lead to sales opportunities.
Strategic Partnerships Partnerships with industry giants such as Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, showcase Vanda's ability to collaborate with key players, opening doors for sales synergies and expanded market reach.
Financial Health Vanda Pharmaceuticals' funding of $54M, revenue ranging between $50M - $100M, and recent executive bonuses highlight financial stability, positioning the company well for potential sales growth and investment opportunities.
Innovative Therapies Vanda's focus on developing innovative therapies to address medical needs and improve patient lives presents unique selling propositions that can attract interest from healthcare providers and drive sales growth in the market.
201
$50M$100M
201$50M$100M
10K$1B
702$100M$1B
72$10M
21
595$50M$100M
275$50M$100MVanda Pharmaceuticals uses 8 technology products and services including SAP, Microsoft Dynamics, Microsoft Dynamics SL, and more. Explore Vanda Pharmaceuticals's tech stack below.
| Vanda Pharmaceuticals Email Formats | Percentage |
| First.Last@vandapharma.com | 98% |
| First.Middle@vandapharma.com | 1% |
| Last@vandapharma.com | 1% |
Pharmaceutical ManufacturingDistrict of Columbia, United States201-500 Employees
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients.
Company Overview
Media & News
Funding & FinancialsVanda Pharmaceuticals has raised a total of $54M of funding over 2 rounds. Their latest funding round was raised on Oct 29, 2014 in the amount of $54M.
Vanda Pharmaceuticals's revenue is in the range of $50M$100M
Funding & FinancialsVanda Pharmaceuticals has raised a total of $54M of funding over 2 rounds. Their latest funding round was raised on Oct 29, 2014 in the amount of $54M.
Vanda Pharmaceuticals's revenue is in the range of $50M$100M
1-888-653-2347 
support@leadiq.com